Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia

被引：1

作者：

D'Arena, Giovanni ^{[1
]}

Volpe, Silvestro ^{[2
]}

Amodeo, Rachele ^{[3
]}

Tirino, Virginia ^{[4
]}

D'Auria, Fiorella ^{[5
]}

Annamaria, Giordano ^{[6
]}

Pietrantuono, Giuseppe ^{[7
]}

Laurenti, Luca ^{[8
]}

Aiello, Antonella ^{[9
]}

Musto, Pellegrino ^{[10
,11
]}

机构：

[1] ASL Salerno, PO S Luca, Hematol, I-84078 Vallo Della Lucania, Italy

[2] AORN Giuseppe Moscati, Immunohematol Unit, Avellino, Italy

[3] St Andrea Hosp, Flow Cytometry Unit, Clin Lab, Rome, Italy

[4] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy

[5] IRCCS Ctr Riferimento Oncol Basilicata, Lab Clin & Adv Diagnost, Rionero In Vulture, Italy

[6] AOUC Policlin, Hematol Unit & Stem Cell Transplantat, Bari, Italy

[7] IRCCS Ctr Riferimento Oncol Basilicata, Hematol & Stem Cell Transplantat Unit, Rionero In Vulture, Italy

[8] Univ Cattolica Sacro Cuore, Hematol Unit IRCCS Fdn Policlin Gemelli, Rome, Italy

[9] Fdn IRCCS, Ist Nazl Tumori, Dept Pathol & Lab Med, Milan, Italy

[10] Aldo Moro Univ, Dept Emergency & Organ Transplantat, Sch Med, Bari, Italy

[11] AOUC Policlin, Unit Hematol & Stem Cell Transplantat, Bari, Italy

来源：

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2022年 / 44卷 / 03期

关键词：

chronic lymphocytic leukemia; flow cytometry; minimal residual disease; prognosis; standardization;

D O I：

10.1111/ijlh.13766

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E120 / E122

页数：3

共 11 条

[1] Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal? [J].

Del Giudice, Ilaria ;

Raponi, Sara ;

Della Starza, Irene ;

De Propris, Maria Stefania ;

Cavalli, Marzia ;

De Novi, Lucia Anna ;

Cappelli, Luca Vincenzo ;

Ilari, Caterina ;

Cafforio, Luciana ;

Guarini, Anna ;

Foa, Robin .

FRONTIERS IN ONCOLOGY, 2019, 9

[2] Chronic lymohocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Eichhorst, B. ;

Robak, T. ;

Montserrat, E. ;

Ghia, P. ;

Niemann, C. U. ;

Kater, A. P. ;

Gregor, M. ;

Cymbalista, F. ;

Buske, C. ;

Hillmen, P. ;

Hallek, M. ;

Mey, U. .

ANNALS OF ONCOLOGY, 2021, 32 (01) :23-33

[3]

*EUR MED AG, 2014, GUID US MIN RES DIS

[4] Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine? [J].

Fuerstenau, Moritz ;

De Silva, Nisha ;

Eichhorst, Barbara ;

Hallek, Michael J. .

HEMASPHERE, 2019, 3 (05)

[5] iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillermo ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael ;

Montserrat, Emili ;

Chiorazzi, Nicholas ;

Stilgenbauer, Stephan ;

Rai, Kanti R. ;

Byrd, John C. ;

Eichhorst, Barbara ;

O'Brien, Susan ;

Robak, Tadeusz ;

Seymour, John F. ;

Kipps, Thomas J. .

BLOOD, 2018, 131 (25) :2745-2760

[6] Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia [J].

Minervini, Crescenzio Francesco ;

Cumbo, Cosimo ;

Redavid, Immacolata ;

Conserva, Maria Rosa ;

Orsini, Paola ;

Zagaria, Antonella ;

Anelli, Luisa ;

Coccaro, Nicoletta ;

Tota, Giuseppina ;

Impera, Luciana ;

Parciante, Elisa ;

Tarantini, Francesco ;

Giordano, Annamaria ;

Specchia, Giorgina ;

Musto, Pellegrino ;

Albano, Francesco .

SCIENTIFIC REPORTS, 2021, 11 (01)

[7] International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia [J].

Rawstron, A. C. ;

Villamor, N. ;

Ritgen, M. ;

Boettcher, S. ;

Ghia, P. ;

Zehnder, J. L. ;

Lozanski, G. ;

Colomer, D. ;

Moreno, C. ;

Geuna, M. ;

Evans, P. A. S. ;

Natkunam, Y. ;

Coutre, S. E. ;

Avery, E. D. ;

Rassenti, L. Z. ;

Kipps, T. J. ;

Caligaris-Cappio, F. ;

Kneba, M. ;

Byrd, J. C. ;

Hallek, M. J. ;

Montserrat, E. ;

Hillmen, P. .

LEUKEMIA, 2007, 21 (05) :956-964

[8] A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study [J].

Rawstron, A. C. ;

Fazi, C. ;

Agathangelidis, A. ;

Villamor, N. ;

Letestu, R. ;

Nomdedeu, J. ;

Palacio, C. ;

Stehlikova, O. ;

Kreuzer, K-A ;

Liptrot, S. ;

O'Brien, D. ;

de Tute, R. M. ;

Marinov, I. ;

Hauwel, M. ;

Spacek, M. ;

Dobber, J. ;

Kater, A. P. ;

Gambell, P. ;

Soosapilla, A. ;

Lozanski, G. ;

Brachtl, G. ;

Lin, K. ;

Boysen, J. ;

Hanson, C. ;

Jorgensen, J. L. ;

Stetler-Stevenson, M. ;

Yuan, C. ;

Broome, H. E. ;

Rassenti, L. ;

Craig, F. ;

Delgado, J. ;

Moreno, C. ;

Bosch, F. ;

Egle, A. ;

Doubek, M. ;

Pospisilova, S. ;

Mulligan, S. ;

Westerman, D. ;

Sanders, C. M. ;

Emerson, R. ;

Robins, H. S. ;

Kirsch, I. ;

Shanafelt, T. ;

Pettitt, A. ;

Kipps, T. J. ;

Wierda, W. G. ;

Cymbalista, F. ;

Hallek, M. ;

Hillmen, P. ;

Montserrat, E. .

LEUKEMIA, 2016, 30 (04) :929-936

[9] Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL [J].

Rawstron, A. C. ;

Boettcher, S. ;

Letestu, R. ;

Villamor, N. ;

Fazi, C. ;

Kartsios, H. ;

de Tute, R. M. ;

Shingles, J. ;

Ritgen, M. ;

Moreno, C. ;

Lin, K. ;

Pettitt, A. R. ;

Kneba, M. ;

Montserrat, E. ;

Cymbalista, F. ;

Hallek, M. ;

Hillmen, P. ;

Ghia, P. .

LEUKEMIA, 2013, 27 (01) :142-149

[10] Minimal Residual Disease in Chronic Lymphocytic Leukemia in the Era of Novel Agents A Review [J].

Thompson, Meghan ;

Brander, Danielle ;

Nabhan, Chadi ;

Mato, Anthony .

JAMA ONCOLOGY, 2018, 4 (03) :394-400

← 1 2 →